Amplified Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Amplified Sciences's estimated annual revenue is currently $2.3M per year.
- Amplified Sciences's estimated revenue per employee is $155,000
Employee Data
- Amplified Sciences has 15 Employees.
- Amplified Sciences grew their employee count by 15% last year.
Amplified Sciences's People
Name | Title | Email/Phone |
---|
Amplified Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $5.7M | 37 | 6% | N/A | N/A |
#3 | $10.2M | 66 | 6% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.6M | 49 | -2% | N/A | N/A |
#7 | $0.8M | 5 | -17% | N/A | N/A |
#8 | $7.9M | 51 | 6% | N/A | N/A |
#9 | $37.7M | 243 | -2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Amplified Sciences?
Imagine a world in which devastating disease such as cancer or organ loss is detected sooner; thus, providing doctors the ability to treat patients earlier with better outcomes. Amplified Sciences is a startup life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases. The company leverages IP licensed from Purdue University and has developed a platform that can scale to point of care. The lead assay is an ultra-sensitive molecular sensing technology revolutionizing #pancreaticcancer. Enabling early detection of debilitating diseases across oncology, cardiovascular, and chronic kidney disease. @Purdue Foundry #moleculardiagnostics #IVD #liquidbiopsy
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 15 | -32% | N/A |
#2 | $3.4M | 17 | 6% | N/A |
#3 | $1.6M | 18 | -10% | N/A |
#4 | $1.8M | 18 | 0% | $114.3M |
#5 | $1.6M | 18 | 6% | N/A |